Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-10-12 DOMAIN PARTERS VII L P 10% owner Conversion · Series B Preferred Stock −1,206,836 0
2016-10-12 DOMAIN PARTERS VII L P 10% owner Conversion · Series C Preferred Stock −836,722 0
2016-10-12 DOMAIN PARTERS VII L P 10% owner Conversion · Series D Preferred Stock −597,207 0
2016-10-12 DOMAIN PARTERS VII L P 10% owner Conversion · Series E Preferred Stock −482,326 0
2016-10-12 Kamdar Kim P. Director Purchase +13,400 $15.00 $201K 13,400
2016-10-12 Stevenson Sharon Director Conversion +190,780 190,780
2016-10-12 Stevenson Sharon Director Conversion +266,829 457,609
2016-10-12 Stevenson Sharon Director Conversion +40,995 498,604
2016-10-12 Stevenson Sharon Director Conversion +161,504 161,504
2016-10-12 Stevenson Sharon Director Conversion +119,441 280,945
2016-10-12 Stevenson Sharon Director Conversion +47,629 546,233
2016-10-12 Stevenson Sharon Director Conversion +60,290 341,235
2016-10-12 Stevenson Sharon Director Conversion · Series A Preferred Stock −143,677 0
2016-10-12 Stevenson Sharon Director Conversion · Series B Preferred Stock −266,829 0
2016-10-12 Stevenson Sharon Director Conversion · Series C Preferred Stock −40,995 0
2016-10-12 Stevenson Sharon Director Conversion · Series C Preferred Stock −161,504 0
2016-10-12 Stevenson Sharon Director Conversion · Series D Preferred Stock −119,441 0
2016-10-12 Stevenson Sharon Director Conversion · Series E Preferred Stock −47,629 0
2016-10-12 Stevenson Sharon Director Conversion · Series E Preferred Stock −60,290 0
2016-10-12 Stevenson Sharon Director Conversion · Series C Preferred Stock Warrant (right to buy) −4,037 0

Page 16 of 17 · 322 trades